[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Carlsmed Inc (CARL)

Carlsmed Inc (CARL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 438,213
  • Shares Outstanding, K 27,303
  • Annual Sales, $ 50,510 K
  • Annual Income, $ -29,630 K
  • EBIT $ -39 M
  • EBITDA $ -38 M
  • 60-Month Beta N/A
  • Price/Sales 8.92
  • Price/Cash Flow N/A
  • Price/Book 5.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 2
  • High Estimate $-0.41
  • Low Estimate $-0.42
  • Prior Year $-0.40
  • Growth Rate Est. (year over year) -2.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.70 +50.00%
on 07/23/26
17.23 -6.85%
on 08/21/26
+4.55 (+39.57%)
since 07/21/26
3-Month
9.48 +69.24%
on 06/23/26
17.23 -6.85%
on 08/21/26
+3.40 (+26.88%)
since 05/21/26
52-Week
8.50 +88.82%
on 04/29/26
17.23 -6.85%
on 08/21/26
+3.17 (+24.61%)
since 08/21/25

Most Recent Stories

More News
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

Second quarter 2026 revenue of $18.9 million, representing 57% growth year-over-year Full year 2026 revenue guidance raised to $74 million to $78 million CARLSBAD, Calif., Aug. 05, 2026 (GLOBE...

CARL : 16.05 (-2.73%)
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

CARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery...

CARL : 16.05 (-2.73%)
Carlsmed, Inc. To Participate in Upcoming Investor Conferences

CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery...

CARL : 16.05 (-2.73%)
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026

CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery...

CARL : 16.05 (-2.73%)
Carlsmed® Reports First Quarter 2026 Financial Results 

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE...

CARL : 16.05 (-2.73%)
Carlsmed, Inc. To Participate in Upcoming Investor Conferences

CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer,...

CARL : 16.05 (-2.73%)
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

CARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report...

CARL : 16.05 (-2.73%)
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at...

CARL : 16.05 (-2.73%)
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results 

Fourth quarter revenue of $15.2 million; 61% growth YoY  Full year revenue of $50.5 million; 86% growth YoY   CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL)...

CARL : 16.05 (-2.73%)
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at...

CARL : 16.05 (-2.73%)

Business Summary

Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif.

See More

Key Turning Points

3rd Resistance Point 18.07
2nd Resistance Point 17.65
1st Resistance Point 16.85
Last Price 16.05
1st Support Level 15.63
2nd Support Level 15.21
3rd Support Level 14.41

See More

52-Week High 17.23
Last Price 16.05
Fibonacci 61.8% 13.90
Fibonacci 50% 12.86
Fibonacci 38.2% 11.83
52-Week Low 8.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.